The Optimal Management of Fistulizing Crohn’s Disease: Evidence beyond Randomized Clinical Trials

Fistulizing Crohn’s disease (FCD) remains the most challenging aspect of treating patients with CD. FCD can occur in up to 30% of patients with CD and may lead to significant disability and impaired quality of life. The optimal treatment strategies for FCD require a multidisciplinary approach, inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wetwittayakhlang, Panu, Al Khoury, Alex, Hahn, Gustavo Drügg, Lakatos, Peter Laszlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181669/
https://www.ncbi.nlm.nih.gov/pubmed/35683433
http://dx.doi.org/10.3390/jcm11113045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181669/
https://www.ncbi.nlm.nih.gov/pubmed/35683433
http://dx.doi.org/10.3390/jcm11113045

Ejemplares similares